Cargando…
Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
CONTEXT: Previous studies have shown that the endocannabinoid system plays a major role in energy metabolism through the actions of its main mediators, 2-arachidonoyl-sn-glycerol (2-AG) and anandamide (AEA). OBJECTIVE: We examined serum levels of major endocannabinoid mediators and their association...
Autores principales: | Moradi, Hamid, Park, Christina, Igarashi, Miki, Streja, Elani, Argueta, Donovan A, Soohoo, Melissa, Daglian, Jennifer, You, Amy S, Rhee, Connie M, Kashyap, Moti L, DiPatrizio, Nicholas V, Vaziri, Nosratola D, Kalantar-Zadeh, Kamyar, Piomelli, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767629/ https://www.ncbi.nlm.nih.gov/pubmed/31583368 http://dx.doi.org/10.1210/js.2019-00242 |
Ejemplares similares
-
Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
por: Chua, Janice T., et al.
Publicado: (2019) -
Inverse Association Between Serum Non–High‐Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis
por: Chang, Tae Ik, et al.
Publicado: (2018) -
Statin Therapy Before Transition to End‐Stage Renal Disease With Posttransition Outcomes
por: Soohoo, Melissa, et al.
Publicado: (2019) -
Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
por: Streja, Elani, et al.
Publicado: (2016) -
Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans
por: Soohoo, Melissa, et al.
Publicado: (2021)